--- title: "HeartBeam, Inc. (BEAT.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/BEAT.US.md" symbol: "BEAT.US" name: "HeartBeam, Inc." industry: "Health Care Equipment" datetime: "2026-05-20T06:51:31.151Z" locales: - [en](https://longbridge.com/en/quote/BEAT.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/BEAT.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/BEAT.US.md) --- # HeartBeam, Inc. (BEAT.US) ## Company Overview HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Exchange | US Market | | Website | [www.heartbeam.com](https://www.heartbeam.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 1970-01-01T00:00:00.000Z **Overall: (0.00)** ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -2.39 | 105 | - | - | - | | PB | 76.29 | 144 | 138.34 | 15.26 | 7.36 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-05-15T04:00:00.000Z Total Analysts: **4** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 2 | 50% | | Overweight | 1 | 25% | | Hold | 1 | 25% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 0.90 | | Highest Target | 5.50 | | Lowest Target | 4.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BEAT.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BEAT.US/norm.md) - [Related News](https://longbridge.com/en/quote/BEAT.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BEAT.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**